Navigation Links
Alpharadin in Medical News

Driven by Launch of Emerging Therapies, Overall Prostate Cancer Drug Market Will Increase by $2 Billion Through 2018

... AstraZeneca's zibotentan, Johnson & Johnson's abiraterone and Algeta's alpharadin will fuel market growth. Specifically, sales of Avastin will be driven by its use in combination with Taxotere and sales of alpharadin will be driven by its use in patients who are not suitable for treatment wi...

Algeta Receives IND Approval for Alpharadin(TM) to Commence Clinical Development in the USA

... biodistribution and dosimetry study (BC1-08) with alpharadin in HRPC patients with skeletal metastases will be ...nternational pivotal phase III clinical trial with alpharadin in HRPC patients during the first half of 2008." ...efore mid 2008 based on positive Phase II results. alpharadin is a novel bone-seeking therapeutic based on the a...
Alpharadin in Medical Technology

Algeta Completes Comprehensive Phase II Clinical Program With Alpharadin for Treating Bone Metastases in Patients With Advanced Prostate Cancer

OSLO, Norway, January 14 /PRNewswire-FirstCall/ -- - Results Highlight the Potential of Alpharadin to Treat Bone Metastases in Major Cancer Indications Algeta ASA (OSE: ALGETA), the cancer therapeutics company, announces that with the results of the BC1-04 study reported today i...

Algeta Reports Positive Headline Phase II Data on Pain Palliation With Alpharadin

OSLO, August 28 /PRNewswire-FirstCall/ -- - Results Further Support the Clinical Profile of This Novel Anti-Cancer Agent Under Development to Improve the Survival of Patients With Hormone Refractory Prostate Cancer (HRPC) Algeta ASA (OSE: ALGETA), the Norwegian cancer therapeutics company,...

Algeta to Present Phase II Clinical Study Data for Alpharadin in Prostate Cancer at ASCO

OSLO, Norway, 30 May 2007 - Algeta ASA (OSE: ALGETA), the Norwegian cancer therapeutics company, announces that Professor Øyvind Bruland, of the Norwegian Radium Hospital, Oslo and founder of Algeta, will present a Poster and Discussion entitled, "Radium-223 in the treatment of metastatic h...

Algeta Demonstrates Targeted Cancer-killing Potential of Novel Alpha Particle Linked Antibodies in Leading Medical Journal Blood

...ellent Phase II clinical data for our lead product alpharadin (radium-223) in prostate cancer, which was publish...rostate cancer based on positive Phase II results. alpharadin is a novel bone-seeking therapeutic based on the a...o Stock Exchange in March 2007 (Ticker: ALGETA). alpharadin and Algeta are trademarks of Algeta ASA. Forward...
Alpharadin in Biological Technology

New Report Just Published: World Prostate Cancer Therapeutics Market Report

...udies II-53 Debiopharm Unveils Results of Phase III Study of Trelstar in Prostate Cancer Treatment II-53 Algeta to Start Clinical Study of alpharadin in HRPC II-53 Ferring Receives FDA Approval for Degarelix in Prostate Cancer II-53 Isis and OncoGenex Reveals Positive results of OGX-011 ...

Algeta Appoints Andrew Kay as President and Chief Executive Officer

...ties and Aims to Accelerate Further Development of alpharadin in Advanced Prostate Cancer Algeta ASA (OS...will be of significant value to Algeta in bringing alpharadin to market." Mr. Kay said: "I am delighted ...g Algeta at this crucial point in its development. alpharadin has shown in all the clinical trials completed to ...
Other Tags
(Date:9/2/2014)... By Steven Reinberg ... -- A device intended to help with weight loss by ... to meet expectations in a trial among obese patients. ... between the brain and stomach, researchers hoped to suppress feelings ... they anticipated. "A device that safely blocks the nerve ...
(Date:9/2/2014)... HealthDay Reporter TUESDAY, ... outbreak continues to overwhelm health-care workers in three West ... the United Nations called on Tuesday for a concerted ... often-fatal virus. Dr. Thomas Frieden, director of the ... without a greater global commitment in resources -- both ...
(Date:9/2/2014)... ALEXANDRIA, VAThe latest research on sleep apnea, tonsillectomies, ... otolaryngic topics will be presented in Orlando, FL, ... OTO EXPO℠ of the American Academy of OtolaryngologyHead ... meeting of ear, nose, throat, head and neck ... research to be presented were released today, and ...
(Date:9/2/2014)... When weather conditions are right, tornadoes can occur ... a path of destruction. In fact, the United States leads ... tornadoes per year. Rainbow International offers the following safety tips ... , Select a safe place such as ... with no windows to stay during the storm. If a ...
(Date:9/2/2014)... Ticket Down is a reputable source for ... will be an exciting week for soccer fans in the ... and Bolivia will battle on U.S. soil in friendly exhibition ... 5th - September 9th: , Brazil vs. Ecuador Tickets ... Mexico vs. Chile Tickets at Levi's Stadium on Saturday, ...
Breaking Medicine News(10 mins):Health News:Nerve Blocking Procedure Fails to Impress in Weight Loss Study 2Health News:Nerve Blocking Procedure Fails to Impress in Weight Loss Study 3Health News:More Global Help Needed to Fight Ebola Outbreak 2Health News:More Global Help Needed to Fight Ebola Outbreak 3Health News:Act Quickly in Case of Tornado: Rainbow International® Offers Tips on How to Be Prepared for a Tornado 2Health News:Ticket Down Substantially Slashes Ticket Prices on Brazil vs. Ecuador Tickets, Brazil vs. Colombia Tickets, Mexico vs. Chile Tickets and Mexico vs. Bolivia Tickets 2Health News:Ticket Down Substantially Slashes Ticket Prices on Brazil vs. Ecuador Tickets, Brazil vs. Colombia Tickets, Mexico vs. Chile Tickets and Mexico vs. Bolivia Tickets 3
(Date:9/2/2014)... lithographic limestone is well known as a result ... area (for example, Archaeopteryx). Now, for the first ... French equivalent of these outcrops - discoveries which ... water treader. , Despite the abundance of fossils ... been obtained from the Late Kimmeridgian equivalents of ...
(Date:9/2/2014)... New Haven, Conn. Yale Cancer Center researchers may ... to sabotage cancer cells made vulnerable by deficient DNA ... journal Scientific Reports . , The study, ... therapeutic radiology at Yale School of Medicine, found that ... inability to repair their own genetic damage) were significantly ...
(Date:9/2/2014)... It,s hard to comprehend how bad the current rate ... knowing what it was before people came along. The ... times lower than scientists had thought, which means that ... are about 1,000 times more frequent now than in ... explanation from lead author Jurriaan de Vos, a Brown ...
Breaking Biology News(10 mins):Exceptionally well preserved insect fossils from the Rhône Valley 2Sabotage as therapy: Aiming lupus antibodies at vulnerable cancer cells 2Extinctions during human era worse than thought 2Extinctions during human era worse than thought 3
Other Contents